ARTICLE | Finance
BioMarin chronicles
March 27, 2006 8:00 AM UTC
Weekly stock price of BioMarin (BMRN; SWX:BMRN) tracked against selected events since the start of 2004.
A. 4/21/04 - BMRN says it will pay $175M for the Ascent Pediatrics business of Medicis (MRX) in a move to become a "fully integrated pediatrics-focused biopharmaceutical company." The deal provides Orapred, a corticosteroid to treat asthma in children, and a 73-person sales force...